Expression of brain-derived neurotrophic factor in serum of patients with obstructive sleep apnea-hypopnea syndrome and its clinical value

CHEN Jing,JIANG Hong
DOI: https://doi.org/10.13329/j.cnki.zyyjk.2013.23.063
2013-01-01
Abstract:[Objective]To investigate the expression status of brain-derived neurotrophic factor( BDNF) in serum of patients with obstructive sleep apnea-hypopnea syndrome( OSAHS) and its clinical value.[Methods]20 normal controls and 42 OSAHS patients were enrolled in this study. According to the apnea hypopnea index( AHI),patients were divided into 3 groups: mild OSAHS group( n = 12),moderate OSAHS group( n = 19) and severe OSAHS group( n = 11). AHI,Epworth sleepiness scale( ESS) scores and the lowest oxygen saturation( LSaO2) of patients were recorded. The levels of serum BDNF were measured by ELISA. [Results]Compared with the normal control group,the levels of serum BDNF in OSAHS groups increased significantly( P <0. 01),and the serum BDNF level elevated with the severity of OSAHS( P < 0. 01). Linear correlation analysis suggested that serum BDNF levels were positively correlated with the AHI( r = 0. 815) and ESS( r = 0. 631),but negatively correlated with the LSaO2( r =-0.723).[Conclusion]The serum BDNF levels in OSAHS patients increase significantly,which are positively correlated with AHI and ESS,but negatively correlated with the LSaO2. So BDNF can be used as an important predictor of OSAHS.
What problem does this paper attempt to address?